Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

In their quest to replicate themselves, viruses have gotten awfully good at tricking human cells into pumping out viral proteins. That's why scientists have been working to use viruses as forces for good: to deliver useful genes to human cells and help patients who lack important proteins or enzymes.

12 May 2017

Researchers use big data to assess impact of infected animal carriers in Ebola virus spread

IBM announced its researchers have used big data analytics to assess the impact of infected animal carriers, or an animal reservoir, in the spread of the Ebola virus in a way not been previously done for earlier disease models.

5 May 2017

Early blood test can predict vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.

26 Apr 2017

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

An international team based at Geneva University Hospitals and at the University of Geneva, Switzerland, has succeeded in defining a "signature" composed of a small number of inflammatory markers that can be monitored in order to understand how a promising anti-Ebola virus vaccine stimulates the immune system.

19 Apr 2017

International research effort reveals major insights into spread of West African Ebola epidemic

An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.

12 Apr 2017

NIH study provides unprecedented detail on host response to Ebola virus disease

Analysis of daily gene activation in a patient with severe Ebola virus disease cared for at the National Institutes of Health (NIH) in 2015 found changes in antiviral and immune response genes that pinpointed key transition points in the response to infection.

12 Apr 2017

Guidelines for disposal of liquid waste from Ebola patients could put sewer workers at risk

Research from Drexel University and the University of Pittsburgh suggests that guidelines for safe disposal of liquid waste from patients being treated for the Ebola virus might not go far enough to protect water treatment workers from being exposed.

11 Apr 2017

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.

6 Apr 2017

Experimental treatment cures Marburg and Ravn virus infection in animals

Scientists funded by the National Institutes of Health have found that an experimental treatment cured 100 percent of guinea pigs and rhesus monkeys in late stages of infection with lethal levels of Marburg and Ravn viruses, relatives of the Ebola virus.

5 Apr 2017

New CDISC data standard assists in development of potential Ebola treatments

The Clinical Data Interchange Standards Consortium and the Infectious Diseases Data Observatory announce the availability of a new standard to assist in the collection, aggregation and analysis of Ebola virus disease research data.

24 Mar 2017

Review of research on wild primates underscores importance of super-spreaders in disease transmission

An extensive review of research on wild primate social networks and parasites underscores the importance of super-spreaders, or central individuals that play an outsized role in transmission of a pathogen.

21 Mar 2017

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

21 Mar 2017

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

Cells infected by the deadly Ebola virus may release viral proteins such as VP40 packaged in exosomes, which, as new research indicates, can affect immune cells throughout the body impairing their ability to combat the infection and to seek out and destroy hidden virus.

16 Mar 2017

New class of membrane-busting compounds can combat MRSA skin infections in mice

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases.

15 Mar 2017

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.

15 Mar 2017

New study examines immune responses to Ebola vaccines at one year after immunization

Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

14 Mar 2017

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

13 Mar 2017

Researchers find new evidence to support structure-based classification system for viruses

Professor Robert Sinclair at the Okinawa Institute of Science and Technology Graduate University and Professor Dennis Bamford and Dr. Janne Ravantti from the University of Helsinki have found new evidence to support a classification system for viruses based on viral structure.

23 Feb 2017

Kent researchers identify how Ebola viruses need few mutations to adapt to new host species

Kent researchers have identified how few mutations it can take for Ebolaviruses to adapt to affect previously resistant species.

15 Feb 2017

UTA scientist develops portable breath monitor to detect flu virus

Perena Gouma, a professor in the Materials Science and Engineering Department at The University of Texas at Arlington, has published an article in the journal Sensors that describes her invention of a hand-held breath monitor that can potentially detect the flu virus.

31 Jan 2017

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

Researchers use big data to assess impact of infected animal carriers in Ebola virus spread

Early blood test can predict vaccine immunogenicity

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

International research effort reveals major insights into spread of West African Ebola epidemic

NIH study provides unprecedented detail on host response to Ebola virus disease

Guidelines for disposal of liquid waste from Ebola patients could put sewer workers at risk

Antibody treatment protects non-human primates against deadly Marburg and Ravn viruses

Experimental treatment cures Marburg and Ravn virus infection in animals

New CDISC data standard assists in development of potential Ebola treatments

Review of research on wild primates underscores importance of super-spreaders in disease transmission

Treatment with interferon may ease symptoms of Ebola patients

Research shows how Ebola viral proteins packaged in exosomes affect immune cells

New class of membrane-busting compounds can combat MRSA skin infections in mice

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

New study examines immune responses to Ebola vaccines at one year after immunization

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Researchers find new evidence to support structure-based classification system for viruses

Kent researchers identify how Ebola viruses need few mutations to adapt to new host species

UTA scientist develops portable breath monitor to detect flu virus

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in